Prognostic factors in advanced pancreatic cancer patients receiving second-line chemotherapy: a single institution experience-Reference-Cited by-同舟云学术

Prognostic factors in advanced pancreatic cancer patients receiving second-line chemotherapy: a single institution experience

Published:2018-10 Issue:5 Volume:7 Page:1190-1198
ISSN:2218-676X
Container-title:Translational Cancer Research
language:
Short-container-title:Transl. Cancer Res

Author:

Bittoni Alessandro,Pellei Chiara,Lanese Andrea,Giampieri Riccardo,D’Angelo Andrea,Giglio Enrica,Cantini Luca,Meletani Tania,Baleani Maria Giuditta,Berardi Rossana

Publisher

AME Publishing Company

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

http://tcr.amegroups.com/article/download/24022/pdf

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Effect of Preoperative Inflammatory Markers on Morbidity and Overall Survival in Pancreatic Adenocarsinoma;Nigerian Journal of Clinical Practice;2023-12

2. Second-line palliative chemotherapy, survival, and prognostic factors in patients with advanced pancreatic cancer;Acta Oncologica;2021-09-06

3. Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer;Annals of Translational Medicine;2021-02

4. Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy;Canadian Association of Radiologists Journal;2020-11-05

5. Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens;BMC Cancer;2020-07-08